# Adaptive Individualized High-Dose Radiotherapy Analysis-REctum-1 (AIDA-RE-1)

> **NCT03479814** · NA · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 9 (estimated)

## Conditions studied

- Rectal Cancer
- Radiotherapy
- Neoadjuvant Treatment

## Interventions

- **RADIATION:** IMRT-SIB plus sequential IG-RT boost

## Key facts

- **NCT ID:** NCT03479814
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479814, "Adaptive Individualized High-Dose Radiotherapy Analysis-REctum-1 (AIDA-RE-1)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03479814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*